Post by : Bianca
Haleem
In a significant move towards advancing medical technology, Sharjah has allocated $2 million to bolster the innovative development of the “Magdi Yacoub Valve” project. This funding exemplifies the Emirate’s dedication to fostering scientific research that can potentially change lives on a global scale.
Under the guidance of esteemed cardiac surgeon Professor Sir Magdi Yacoub, the Magdi Yacoub Valve project aims to engineer a pioneering heart valve using a biocompatible fiber scaffold. This scaffold is designed to dissolve over time, enabling the patient’s own cells to create a functional living valve. Such a breakthrough could significantly lower the necessity for repeated surgeries and minimize rejection risks, providing new hope to millions of patients around the world.
The funding will be administered through the Sharjah Research, Technology and Innovation Park (SPARK), an incubator that supports bridging academic research with practical applications. SPARK’s involvement ensures that groundbreaking initiatives like the Magdi Yacoub Valve have the essential resources and supportive environment to flourish.
This initiative is aligned with Sharjah’s ambition to become a leading global center for knowledge, innovation, and human progress. By investing in cutting-edge medical research, the Emirate reaffirms its commitment to nurturing talent and supporting projects that yield substantial benefits for humanity.
Renowned for conducting the UK’s first heart-lung transplant, Professor Sir Magdi Yacoub remains at the forefront of cardiac science, with his efforts through the Magdi Yacoub Heart Foundation consistently aimed at enhancing cardiac care and ensuring life-saving innovations reach those in need.
With this funding, Sharjah is not only emerging as a supporter of scientific endeavors but also as a catalyst for innovations that could transform the future of medicine and improve life quality for innumerable patients on a global scale.
English
